Lv5
1030 积分 2025-01-08 加入
Efficacy and safety of monoclonal antibody AK111 in the treatment of active ankylosing spondylitis: a randomised, double-blind, placebo-controlled, multicentre phase II clinical study
4天前
已完结
SYHX1901, an oral dual JAK/SYK inhibitor, for moderate-to-severe plaque psoriasis: a randomized phase 2 trial
4天前
已完结
Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT‐1)
4天前
已完结
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial
11天前
已完结
Abatacept in early polymyalgia rheumatica (ALORS): a proof-of-concept, randomised, placebo-controlled, parallel-group trial
11天前
已关闭
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial
14天前
已完结
Treatment of active ankylosing spondylitis with abatacept: an open-label, 24-week pilot study
15天前
已完结
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial
16天前
已完结
CAR T-cell therapy in systemic sclerosis: the next frontier in immune modulation
2个月前
已完结
[Recommendations for diagnosis and treatment of systemic sclerosis in China]
2个月前
已完结
皖公网安备34019202002308
